208 related articles for article (PubMed ID: 8340253)
1. Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate.
Deguchi J; Kawabata T; Kondo A; Okada S
Jpn J Cancer Res; 1993 Jun; 84(6):649-55. PubMed ID: 8340253
[TBL] [Abstract][Full Text] [Related]
2. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Luo XP; Tanaka T; Uchida K; Hiai H; Lehotay DC
Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats.
Deguchi J; Miyamoto M; Okada S
Jpn J Cancer Res; 1995 Nov; 86(11):1068-71. PubMed ID: 8567398
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate.
Tanaka T; Nishiyama Y; Okada K; Satoh K; Fukuda A; Uchida K; Osawa T; Hiai H; Toyokuni S
Carcinogenesis; 1998 May; 19(5):897-903. PubMed ID: 9635880
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.
Nishiyama Y; Tanaka T; Naitoh H; Mori C; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1997 Feb; 88(2):120-8. PubMed ID: 9119739
[TBL] [Abstract][Full Text] [Related]
7. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Uchida K; Okamoto K; Hattori-Nakakuki Y; Hiai H; Stadtman ER
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2616-20. PubMed ID: 8146163
[TBL] [Abstract][Full Text] [Related]
8. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney.
Uchida K; Fukuda A; Kawakishi S; Hiai H; Toyokuni S
Arch Biochem Biophys; 1995 Mar; 317(2):405-11. PubMed ID: 7893156
[TBL] [Abstract][Full Text] [Related]
9. In vitro transformation of rat renal cells by treatment with ferric nitrilotriacetate.
Kakehashi C; Mori M; Kawabata T; Okada S
Acta Med Okayama; 2001 Apr; 55(2):97-103. PubMed ID: 11332205
[TBL] [Abstract][Full Text] [Related]
10. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA).
Randerath E; Watson WP; Zhou GD; Chang J; Randerath K
Mutat Res; 1995 Feb; 341(4):265-79. PubMed ID: 7531286
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats.
Ebina Y; Okada S; Hamazaki S; Ogino F; Li JL; Midorikawa O
J Natl Cancer Inst; 1986 Jan; 76(1):107-13. PubMed ID: 3455733
[TBL] [Abstract][Full Text] [Related]
12. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.
Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O
Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378
[TBL] [Abstract][Full Text] [Related]
13. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.
Umemura T; Hasegawa R; Sai-Kato K; Nishikawa A; Furukawa F; Toyokuni S; Uchida K; Inoue T; Kurokawa Y
Jpn J Cancer Res; 1996 Sep; 87(9):882-6. PubMed ID: 8878448
[TBL] [Abstract][Full Text] [Related]
14. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats.
Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S
Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562
[TBL] [Abstract][Full Text] [Related]
15. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress.
Athar M; Iqbal M
Carcinogenesis; 1998 Jun; 19(6):1133-9. PubMed ID: 9667754
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney.
Okada S; Fukunaga Y; Hamazaki S; Yamada Y; Toyokuni S
Acta Pathol Jpn; 1991 Mar; 41(3):221-6. PubMed ID: 2068947
[TBL] [Abstract][Full Text] [Related]
17. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Mori T; Dizdaroglu M
Int J Cancer; 1994 Apr; 57(1):123-8. PubMed ID: 8150530
[TBL] [Abstract][Full Text] [Related]
18. Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes.
Ebina Y; Okada S; Hamazaki S; Toda Y; Midorikawa O
Calcif Tissue Int; 1991 Jan; 48(1):28-36. PubMed ID: 2007224
[TBL] [Abstract][Full Text] [Related]
19. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice.
Toyokuni S; Okada S; Hamazaki S; Minamiyama Y; Yamada Y; Liang P; Fukunaga Y; Midorikawa O
Cancer Res; 1990 Sep; 50(17):5574-80. PubMed ID: 2386964
[TBL] [Abstract][Full Text] [Related]
20. Consumption of hydrogen-rich water protects against ferric nitrilotriacetate-induced nephrotoxicity and early tumor promotional events in rats.
Li FY; Zhu SX; Wang ZP; Wang H; Zhao Y; Chen GP
Food Chem Toxicol; 2013 Nov; 61():248-54. PubMed ID: 24140467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
